Teva To Present Multiple Sclerosis Data At 67th American Academy of Neurology Annual Meeting In Washington, D.C.

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that data on COPAXONE® (glatiramer acetate injection), a product for relapsing forms of multiple sclerosis (MS), and laquinimod, an investigational therapy under development for relapsing and progressive forms of MS, will be presented at the American Academy of Neurology (AAN) Annual Meeting in Washington, D.C., April 18-25, 2015.

Help employers find you! Check out all the jobs and post your resume.

Back to news